If you want to make this country great, imagine the strength of a nation whose children have been fought for and know they have been fought for ...

The Association for Research in Vision and Ophthalmology (ARVO) Foundation has announced Maria Vittoria Cicinelli, MD, Denise ...

NORTH CHICAGO, IL, USA I March 15, 2025 I AbbVie (NYSE: ABBV) today announced the final analysis of the confirmatory Phase 3 MIRASOL trial evaluating the ...

Mirvetuximab soravtansine improved overall survival over chemotherapy in patients with FRα-positive, platinum-resistant ovarian cancer.

Europe’s drug regulatory agency has given Kizfizo a negative opinion for the second time, following one from November 2024.

Results from Phase 2 RAINFOLTM-01 trial (B1 cohort) showed that with a median on-study follow-up of 48 weeks, Rina-S 120 mg/m2 led to a confirmed objective response rate (ORR) of 55.6% and median ...

进一步研究发现，拓扑异构酶抑制剂依托泊苷（Etoposide）、替尼泊苷（Teniposide）、拓扑替康（Topotecan）和柔红霉素（Daunorubicin）对 TP53-KO 类器官的抑制作用尤为显著，这也验证了之前基因敲除实验中 TOP2B 与 TP53 的关系。 综合来看，这项研究意义重大。研究人员 ...

Media ReleaseCOPENHAGEN, Denmark; March 17, 2025 Results from Phase 2 RAINFOLTM-01 trial (B1 cohort) showed that with a median on-study follow-up of 48 weeks, Rina-S 120 mg/m2 led to a confirmed objec ...

The stability of treprostinil sodium after dilution in three common i.v. infusion vehicles was assessed. The chemical stability of treprostinil sodium was tested over a 48-hour period at 40 °C ...